China Regenerative Medicine International (HKSE:08158) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08158 China Regenerative Medicine International Ltd HKSE:08158
30 GF Score
Price HK$0.23
GF Value HK$0.63
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is China Regenerative Medicine International FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:08158
30GF Score
China Regenerative Medicine International Ltd HKSE:08158
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China Regenerative Medicine International (HKSE:08158) Overvalued in 2026?

Based on GuruFocus' analysis, China Regenerative Medicine International stock appears to be undervalued. The current stock price of HK$0.23 is trading 63.2% below its estimated GF Value™ of HK$0.63. GuruFocus considers China Regenerative Medicine International to be Possible Value Trap.

Key valuation signals for HKSE:08158:

  • FFO:
  • GF Value™: HK$0.63 vs. price of HK$0.23 (63.2% below fair value)
  • GF Score™: 30/100 with 5 warning signs

No single metric tells the full story. See the HKSE:08158 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Regenerative Medicine International Business Description

Address 132 Nathan Road, Suite 2310-2318, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG
China Regenerative Medicine International Ltd is an investment holding company. The company is engaged in the provision of healthcare products and services. It is engaged in research and development, production and sales of tissue engineering and regenerative medicine products. The business scope of company includes tissue engineering, cosmetics, cell storage, preparation and therapy, hospitals administration and other business division. The segments of the company are Aesthetic medical and beauty services and Medical services. The majority of the company's revenue is derived from its Aesthetic medical and beauty services segment that provides medical beauty products and services. Geographically, the Hong Kong accounts for the majority of the revenue and also has a presence in PRC.
30GF Score

Get the complete analysis for HKSE:08158

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.23
Price
HK$0.63
GF Value